Novozymes A/S
NVZMY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $113,175 | $103,049 | $97,670 | $151,015 |
| - Cash | $280 | $1,116 | $1,041 | $963 |
| + Debt | $1,797 | $7,733 | $411 | $482 |
| Enterprise Value | $114,692 | $109,666 | $97,040 | $150,534 |
| Revenue | $3,834 | $17,899 | $17,553 | $14,951 |
| % Growth | -78.6% | 2% | 17.4% | – |
| Gross Profit | $1,810 | $9,722 | $9,577 | $8,623 |
| % Margin | 47.2% | 54.3% | 54.6% | 57.7% |
| EBITDA | $8,071 | $5,471 | $6,115 | $5,400 |
| % Margin | 210.5% | 30.6% | 34.8% | 36.1% |
| Net Income | $306 | $3,024 | $3,676 | $3,146 |
| % Margin | 8% | 16.9% | 20.9% | 21% |
| EPS Diluted | 1.1 | 1.46 | 13.19 | 11.23 |
| % Growth | -24.7% | -88.9% | 17.5% | – |
| Operating Cash Flow | $1,020 | $4,152 | $4,006 | $4,062 |
| Capital Expenditures | -$360 | -$2,056 | -$2,890 | -$1,240 |
| Free Cash Flow | $660 | $2,096 | $1,116 | $2,822 |